DRKS00017083招募中不适用
Observational study for the efficacy of add-on non-pharmaceutical interventions and of Viscum album extract for the treatment of patients with lung carcinoma - ACCEPT-2; PHOENIX-III
Forschungsinstitut Havelhöhe (FIH) gGmbH am Gemeinschaftskrankenhaus Havelhöhe0 个研究点目标入组 60 人开始时间: 2019年6月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Written informed consent, patients with primary lung carcinoma (stage UICC IIA - IVB - 8th edition), knowledge of Geman language, can expected to undergo a 3-months program (ECOG 0-2), inclusion within 4 weeks of primary diagnosis, if necessary plus 3 months depending on therapy
排除标准
- •Primary lung carcinoma UICC I (8th edition), no written consent
研究者
相似试验
已完成
不适用
Investigation of efficacy and safety of add-on therapy with DPP-4 inhibitor in type 2 diabetic patients poorly controlled with basal supported oral therapyType 2 diabetesJPRN-UMIN000010849Department of Metabolism & Endocrinology Juntendo University Graduate School of Medicine40
招募中
不适用
Research for predictors of the efficacy of add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptomsBenign Prostatic Hyperplasia Overactive BladderJPRN-UMIN000036799Department of Urology, Fukushima Medical University School of Medicine100
已完成
4 期
Effect of Rejiyana (Acetyl-L-carnitine and Agmatine) in major depressive disorder.CTRI/2023/07/055151Dr. G Prasad Rao60
尚未招募
2 期
DEKSEL Nano Syrup [Vitamin D 6000IU/5mL] in patients with Major Depressive DisorderCTRI/2020/12/030020Pulse Pharmaceuticals Pvt Ltd
尚未招募
不适用
A study to compare the effectiveness of oral fexofenadine combined with topical treatment vs topical treatment alone in treatment of childhood atopic dermatitisCTRI/2019/12/022332PGIMER Chandigarh